B. Braun Etomidate 2 mg/ml Injection
PDF Leaflet Revision Date: 03 August 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Induction of general anaesthesia.
Dosage (summary)
Adults: 0.2-0.3 mg/kg IV; max 3 ampoules.
Onset of Action / Duration
Onset: 30-60 secs, Duration: 3-5 mins
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not established; caution in breastfeeding.
Key Drug Interactions
- Neuroleptics
- Opioids
- Sedatives
- Alcohol
Contraindications
- Hypersensitivity to etomidate or excipients
- Porphyria
- Pregnancy and lactation
- Neonates and infants under 6 months
Common side effects
- Hypotension
- Apnoea
- Myoclonus
- Nausea
- Vomiting
Counselling Points
- Avoid driving or operating machinery for 24 hours.
- Use analgesics as etomidate has no analgesic effect.
- Monitor for respiratory depression.
Serious warnings
- Adrenocortical suppression
- Risk of respiratory depression
- Use with caution in critically ill patients
Important Disclaimer
The B. Braun Etomidate 2 mg/ml Injection professional information leaflet below is the property of B Braun Medical and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
